SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]
SEC Accession No. 0001193125-11-123798
Filing Date
2011-05-03
Accepted
2011-05-03 15:35:33
Documents
14
Period of Report
2011-03-31
Filing Date Changed
2011-05-03

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q d10q.htm 10-Q 596605
2 CONFIRMATION WITH BARCLAYS BANK PLC dex10278.htm EX-10.278 162488
3 TWELFTH AMENDMENT TO LEASE AGREEMENT dex10279.htm EX-10.279 23089
4 CERTIFICATION OF CEO PURSUANT TO RULE 13A-14(A) dex311.htm EX-31.1 10032
5 CERTIFICATION OF CFO PURSUANT TO RULE 13A-14(A) dex312.htm EX-31.2 10038
6 CERTIFICATION OF CEO PURSUANT TO SECTION 1350 dex321.htm EX-32.1 2795
7 CERTIFICATION OF CFO PURSUANT TO SECTION 1350 dex322.htm EX-32.2 2804
13 GRAPHIC g175654g21s24.jpg GRAPHIC 35817
14 GRAPHIC g175654g69o07.jpg GRAPHIC 36112
  Complete submission text file 0001193125-11-123798.txt   2989813

Data Files

Seq Description Document Type Size
8 XBRL INSTANCE DOCUMENT ppdi-20110331.xml EX-101.INS 400223
9 XBRL TAXONOMY EXTENSION SCHEMA ppdi-20110331.xsd EX-101.SCH 18123
10 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE ppdi-20110331_cal.xml EX-101.CAL 43434
11 XBRL TAXONOMY EXTENSION LABEL LINKBASE ppdi-20110331_lab.xml EX-101.LAB 136989
12 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE ppdi-20110331_pre.xml EX-101.PRE 81785
Mailing Address 929 NORTH FRONT STREET WILMINGTON NC 28401
Business Address 929 NORTH FRONT STREET WILMINGTON NC 28401 9102510081
PHARMACEUTICAL PRODUCT DEVELOPMENT INC (Filer) CIK: 0001003124 (see all company filings)

IRS No.: 561640186 | State of Incorp.: NC | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-27570 | Film No.: 11805010
SIC: 8731 Services-Commercial Physical & Biological Research
Assistant Director 1